|

Icotinib Clinical Trials

2 actively recruiting trials

Also known as: Conmana

Pipeline

Phase 2: 2

Top Sponsors

  • Sun Yat-sen University1
  • Peking University Cancer Hospital & Institute1

Indications

  • Lung Cancer2
  • Cancer2
  • EGFR S768I1
  • EGFR L861Q1
  • EGFR G719X1

Other2 trials

A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
Phase 2
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.